High hematocrit resulting from administration of erythropoiesis-stimulating agents is not fully predictive of mortality or toxicities in preclinical species.
Saved in:
| Title: | High hematocrit resulting from administration of erythropoiesis-stimulating agents is not fully predictive of mortality or toxicities in preclinical species. |
|---|---|
| Authors: | Andrews DA; 1Comparative Biology Safety Sciences, Pathology, Amgen, Inc., Thousand Oaks, California, USA., Pyrah IT, Boren BM, Tannehill-Gregg SH, Lightfoot-Dunn RM |
| Source: | Toxicologic pathology [Toxicol Pathol] 2014; Vol. 42 (3), pp. 510-23. Date of Electronic Publication: 2013 May 14. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
